ES
MARKETS / NYSE / CHE
NYSE · SERVICES-HOME HEALTH CARE SERVICES · LARGE CAP

Chemed Corporation CHE

18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY17 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$2.5B
▲ 4.1% vs FY2024
Dividend streak
17 yrs
Raised every year since 2009
EPS · FY25
$18.34
Dividend / sh · FY25
$2.20
Payout · FY25
12%
ROE · FY25
25.3%
Net margin · FY25
10.5%
Dividend coverage
8.3×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.5B
Revenue, FY2025 · full 18-year series below
Revenue Net income
0.81.62.43.22.50.32008201120142017202020232025
0.81.62.43.22.50.32016201920222025

10 cents of every revenue dollar became profit this year.

Per share
USD 18.34
Diluted EPS, FY2025
EPS Dividend
816242.2018.342008201120142017202020232025
816242.2018.342016201920222025

Earnings covered the dividend 8.3 times — the rest stayed in the company.

Profitability
25.3%
Return on equity, FY2025
ROE
1020304025.3%2008201120142017202020232025
1020304025.3%2016201920222025
Operating margin13.4%
Net margin10.5%
Return on assets16.5%

Each USD of equity produced 25 cents of profit this year.

Returned to shareholders
USD 436.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 31.7M
Net buybacksUSD 404.3M
Share of profit164.4%
Consecutive raises17 years

USD 31.7M in dividends and USD 404.3M in buybacks — 164% of the year's profit, so the payout drew on cash built up earlier.

Growth
+13.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+28.2%
+13.6%
+5.1%
+4.6%
Net income
+2.0%
−3.7%
+9.2%
+8.2%
EPS, diluted
+3.5%
−1.2%
+11.2%
+11.6%
Dividend / share
+14.1%
+10.8%
+9.1%
+10.1%
Returned to shareholders
+68.2%
+24.4%
+22.0%
+9.2%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.5B
total assets, end of FY2025
Total assetsUSD 1.5B
EquityUSD 979.4M
CashUSD 74.5M
Current ratio1.05×

Equity funds 64% of total assets.

History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
2.5
2.4
2.3
1.2
1.3
1.3
1.3
1.2
1.7
1.6
1.5
1.5
1.4
1.4
1.4
1.3
1.2
1.1
Operating income $B
0.3
0.4
0.3
0.3
0.3
0.4
0.3
0.2
0.1
0.2
0.2
0.2
0.1
0.2
0.2
0.1
0.1
0.1
EBITDA $B
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.2
Income tax $B
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.0
0.0
Net income $B
0.3
0.3
0.3
0.2
0.3
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
EPS, diluted $
18.34
19.89
17.93
16.53
16.85
19.48
13.31
12.23
5.86
6.48
6.33
5.57
4.16
4.62
4.10
3.55
3.24
2.88
Dividend / sh $
2.20
1.80
1.56
1.48
1.40
1.32
1.24
1.16
1.08
1.00
0.92
0.84
0.76
0.68
0.60
0.52
0.36
0.24
Payout %
12
9
9
9
8
7
9
9
18
15
14
14
18
15
15
15
11
8
ROE %
25.3
27.1
28.6
35.1
35.2
39.3
33.4
36.3
18.4
21.0
22.9
22.1
17.1
20.6
19.6
17.4
15.5
·
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
52 of 52
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed